摘要
背景:初级保健服务通常提供痴呆患者与健康服务提供者之间的初步联系。已经提出早期诊断和筛查方案作为一种可能的策略,以改善对这些个体的识别以及治疗和规划健康和社会护理支持。 目的:确定在初级保健实践中采用了哪些早期诊断和筛查项目,探索谁应该实施这些项目,并确定初级保健中痴呆患者早期诊断和筛查项目可能带来的正面和负面影响。 方法:使用已发表和未发表的研究数据库对文献进行系统回顾。包括所有回答我们研究目标的论文。对文献进行叙述性分析,CASP工具用于评估研究质量。 结果:33篇论文被认定为中高质量。对于那些被诊断患有痴呆症的人来说,有限的治疗选择意味着,即使这样的项目被煽动,其临床价值仍然值得怀疑。此外,由于证据不足,诊断的准确性仍然难以评估,这就提出了人们是否可能被诊断过度或不足的问题。鉴于这种诊断的负面社会和心理后果,这可能是个人的破坏性。 结论:早期诊断和筛查项目尚未广泛应用于初级保健。在有严格证据评估这类方案的临床和成本效益之前,还没有充分的证据支持在实践中采用这些方案。
关键词: 诊断,人口筛查,认知功能障碍,经验,一般实践,社区服务。
Current Alzheimer Research
Title:Systematic Review Investigating Multi-disciplinary Team Approaches to Screening and Early Diagnosis of Dementia in Primary Care – What are the Positive and Negative Effects and Who Should Deliver It?
Volume: 15 Issue: 1
关键词: 诊断,人口筛查,认知功能障碍,经验,一般实践,社区服务。
摘要: Background: Primary care services frequently provide the initial contact between people with dementia and health service providers. Early diagnosis and screening programmes have been suggested as a possible strategy to improve the identification of such individuals and treatment and planning health and social care support.
Objective: To determine what early diagnostic and screening programmes have been adopted in primary care practice, to explore who should deliver these and to determine the possible positive and negative effects of an early diagnostic and screening programme for people with dementia in primary care.
Methods: A systematic review of the literature was undertaken using published and unpublished research databases. All papers answering our research objectives were included. A narrative analysis of the literature was undertaken, with the CASP tools used appropriately to assess study quality.
Results: Thirty-three papers were identified of moderate to high quality. The limited therapeutic options for those diagnosed with dementia means that even if such a programme was instigated, the clinical value remains questionable. Furthermore, accuracy of the diagnosis remains difficult to assess due to poor evidence and this raises questions regarding whether people could be over- or under-diagnosed. Given the negative social and psychological consequences of such a diagnosis, this could be devastating for individuals.
Conclusion: Early diagnostic and screening programmes have not been widely adopted into primary care. Until there is rigorous evidence assessing the clinical and cost-effectiveness of such programmes, there remains insufficient evidence to support the adoption of these programmes in practice.
Export Options
About this article
Cite this article as:
Systematic Review Investigating Multi-disciplinary Team Approaches to Screening and Early Diagnosis of Dementia in Primary Care – What are the Positive and Negative Effects and Who Should Deliver It?, Current Alzheimer Research 2018; 15 (1) . https://dx.doi.org/10.2174/1567205014666170908094931
DOI https://dx.doi.org/10.2174/1567205014666170908094931 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Renal Biopsy Research with Implications for Therapy of Glomerulonephritis
Current Drug Therapy Potential Targets for the Development of Novel Antidepressants: Future Perspectives
CNS & Neurological Disorders - Drug Targets NOAC in Acute Coronary Syndrome and AF?
Cardiovascular & Hematological Disorders-Drug Targets The Impact of Docosahexaenoic Acid on Alzheimer’s Disease: Is There a Role of the Blood-Brain Barrier?
Current Clinical Pharmacology An Insight into the Therapeutic Potential of Major Coffee Components
Current Drug Metabolism Disease Modifying Approaches for Alzheimers Pathology
Current Pharmaceutical Design G-Lymphatic, Vascular and Immune Pathways for Aβ Clearance Cascade and Therapeutic Targets For Alzheimer’s Disease
Combinatorial Chemistry & High Throughput Screening Cerebrovascular Profile Assessment in Parkinson's Disease Patients
CNS & Neurological Disorders - Drug Targets Advanced Drug Delivery of N-Acetylcarnosine (N-Acetyl-beta-alanyl-Lhistidine), Carcinine (Beta-alanylhistamine) and L-carnosine (Beta-alanyl- L-histidine) in Targeting Peptide Compounds as Pharmacological Chaperones for Use in Tissue Engineering, Human Disease Management and Therapy: From in vitro to the Clinic
Recent Patents on Drug Delivery & Formulation Tau as a Therapeutic Target for Alzheimers Disease
Current Alzheimer Research Defining and Regulating Acute Inflammatory Lesion Formation during the Pathogenesis of Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
CNS & Neurological Disorders - Drug Targets Mitochondrial Deficits Accompany Cognitive Decline Following Single Bilateral Intracerebroventricular Streptozotocin
Current Alzheimer Research Lifestyle and Genetic Contributions to Cognitive Decline and Hippocampal Structure and Function in Healthy Aging
Current Alzheimer Research Pharmacotherapy for Late-Life Depression with Psychotic Features: A Review of Literature of Randomized Control Trials
Current Psychiatry Reviews P-Glycoprotein and Breast Cancer Resistance Protein Affect Disposition of Tandutinib, A Tyrosine Kinase Inhibitor
Drug Metabolism Letters Pharmacological Properties of Physical Exercise in The Elderly
Current Pharmaceutical Design Cerebral Microemboli Increase β-amyloid Protein Deposition, MMP-9, and GFAP Expression in the Alzheimer`s Model of APP/PS1 Double Transgenic Mice
Current Neurovascular Research Conantokins Inhibitors of Ion Flow through the N-Methyl-D-Aspartate Receptor Channels
Current Drug Targets Development of BACE1 Inhibitors for Alzheimers Disease
Current Medicinal Chemistry Long-Term Exposure to Ambient Hydrocarbons Increases Dementia Risk in People Aged 50 Years and above in Taiwan
Current Alzheimer Research